All AbMole products are for research use only, cannot be used for human consumption.
Metformin HCl is a biguanide inhibitor that reduces blood glucose mainly by inhibiting hepatic glycogen production (hepatic gluconeogenesis), while Metformin is a CD47 inhibitor in vitro.
Metabolism. 2023 Jan 7;140:155398.
Metformin coordinates with mesenchymal cells to promote VEGF-mediated angiogenesis in diabetic wound healing through Akt/mTOR activation
Metformin hydrochloride purchased from AbMole
Inflamm Res. 2023 Dec 13.
The immunomodulatory effects of metformin in LPS-induced macrophages: an in vitro study
Metformin hydrochloride purchased from AbMole
Neurosci Lett. 2022 Jul 13;783:136708.
Metformin protects against pericyte apoptosis and promotes neurogenesis through suppressing JNK p38 MAPK signalling activation in ischemia/reperfusion injury
Metformin hydrochloride purchased from AbMole
Patent. CN114686433A 2022 Jul 01.
Patent. CN114686433A
Metformin hydrochloride purchased from AbMole
| Molecular Weight | 165.62 |
| Formula | C4H11N5.HCl |
| CAS Number | 1115-70-4 |
| Solubility (25°C) | Water ≥ 30 mg/mL |
| Storage | 2-8°C, protect from light, dry, sealed |
| Related Autophagy Products |
|---|
| NEO214
NEO214 is an autophagy inhibitor and a covalent conjugate of the PDE4 inhibitor Rolipram and perillyl alcohol. NEO214 has anti-cancer activity and blood-brain barrier (BBB) permeability. NEO214 prevents autophagy-lysosome fusion, thereby blocking autophagic flux and triggering glioma cell death. |
| Ammonium chloride-15N
Ammonium chloride-15N is the 15N labeled Ammonium chloride. Ammonium chloride is an autophagy inhibitor. Ammonium chloride is also a lysosome inhibitor. |
| Vacuolin-1
Vacuolin-1 is a cell-permeable inhibitor of Ca2+ dependent fusion of lysosomes to the cell membrane. Vacuolin-1 blocks the Ca2+-dependent exocytosis of lysosomes and prevents the release of lysosomal content without affecting the process of resealing. vacuolin‐1 is a potent and selective PIKfyve inhibitor and inhibits late‐stage autophagy by impairing lysosomal maturation. |
| CA77.1
CA77.1 is a potent, brain-penetrant and orally active chaperone-mediated autophagy (CMA) activator with favorable pharmacokinetics. |
| KAN0438757
KAN0438757 is a potent and selective inhibitor of the metabolic kinase PFKFB3 with an IC50 of 0.19 μM. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
